PCP
EXAS

Pacific Capital Partners’s Exact Sciences EXAS Stock Holding History

Pacific Capital Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,500
Closed -$1.6M – 49
2024
Q4 		$1.6M Hold
28,500
– – 0.94% 31
2024
Q3 		$1.94M Hold
28,500
– – 1.14% 25
2024
Q2 		$1.2M Buy
28,500
+11,862
+71% +$653K 0.8% 37
2024
Q1 		$1.15M Buy
16,638
+3,657
+28% +$231K 0.75% 38
2023
Q4 		$960K Buy
12,981
+3,744
+41% +$245K 0.72% 39
2023
Q3 		$630K Buy
+9,237
New +$784K 0.38% 47

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pacific Capital Partners's EXAS Position: Q1 2025 in Review

Pacific Capital Partners sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 28,500 shares — an estimated $1.6M sold.

Pacific Capital Partners first reported a position in EXAS in Q3 2023 and held it in 6 quarters. The position peaked at $1.94M in Q3 2024. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Pacific Capital Partners reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Pacific Capital Partners sold 28,500 Exact Sciences shares in Q1 2025, an estimated $1.6M.
  • Pacific Capital Partners first reported a position in Exact Sciences in Q3 2023 and held it in 6 quarters.
  • Pacific Capital Partners's Exact Sciences position peaked at $1.94M in Q3 2024.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Pacific Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.